Matches in SemOpenAlex for { <https://semopenalex.org/work/W1931300061> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W1931300061 abstract "Background: Polymerized liposomal nanoparticles (PLNs) are a promising new technology for delivery of chemotherapeutic drugs to cancer cells. They are easy to prepare, biocompatible, and can carry a wide variety of therapeutics. Additionally, PLNs have the potential to be conjugated to a tumor targeting agent in hopes of delivering a cytotoxic payload directly to the cancer cells, thus minimizing systemic toxicity. Cys-diabodies are the smallest tumor antibody fragment (55 Kd) that retain the bivalency of an intact antibody. The goal of this study was to determine our ability to conjugate various engineered cys-diabody fragments to PLNs and to evaluate the ability to specifically target tumor cells based on the specificity of the diabody-tumor antigen interaction. Methods: Cys-diabody constructs against tumor antigens (ALCAM, HER2/neu, Ca19.9) were engineered, expressed in NSO myeloma cells and purified using HPLC. A cysteine residue was inserted at the C-terminus to provide the free sulhydryl group necessary for the conjugation reaction. Using malemide chemistry, cys-diabodies were conjugated to PLNs. Immunofluorescence and flow cytometry were performed to evaluate targeting of conjugated PLNs to human pancreatic and breast cancer cell lines. Unconjugated PLNs and tumor antigen negative cell lines were used as controls. Results: Anti-HER2/neu, ALCAM, and CA19.9 cys-diabodies were characterized by flow cytometry showing specific binding to MCF7 (HER2/neu positive), HPAF (ALCAM positive), and BxPC3 (CA19.9 positive) cell lines, respectively. No binding was observed to antigen-negative cell lines nor with the unconjugated PLNs. Conjugation of cys-diabodies to PLNs was indicated by immunofluorescence showing specific binding of PLN-cys-diabody conjugates to breast and pancreatic cancer cells in vitro (Figure 1). These data were also confirmed by flow cytometry. Conclusions: We have demonstrated the ability to conjugate our PLN with engineered anti-tumor cys-diabodies. Furthermore, we have demonstrated that after conjugation, the PLNs demonstrate specific tumor-cell targeting based on the specificity of the diabody-tumor antigen affinity. These studies represent an important first step in the development of targeted PLNs with the ultimate goal of delivering high doses of a chemotherapeutic directly to the cancer cells." @default.
- W1931300061 created "2016-06-24" @default.
- W1931300061 creator A5005083505 @default.
- W1931300061 creator A5017822750 @default.
- W1931300061 creator A5045636811 @default.
- W1931300061 creator A5068482542 @default.
- W1931300061 creator A5069362975 @default.
- W1931300061 creator A5089132706 @default.
- W1931300061 date "2010-10-01" @default.
- W1931300061 modified "2023-09-26" @default.
- W1931300061 title "Targeting cancer with cys-diabody conjugated polymerized liposomal nanoparticles (PLNs)" @default.
- W1931300061 doi "https://doi.org/10.1158/diag-10-a20" @default.
- W1931300061 hasPublicationYear "2010" @default.
- W1931300061 type Work @default.
- W1931300061 sameAs 1931300061 @default.
- W1931300061 citedByCount "0" @default.
- W1931300061 crossrefType "proceedings-article" @default.
- W1931300061 hasAuthorship W1931300061A5005083505 @default.
- W1931300061 hasAuthorship W1931300061A5017822750 @default.
- W1931300061 hasAuthorship W1931300061A5045636811 @default.
- W1931300061 hasAuthorship W1931300061A5068482542 @default.
- W1931300061 hasAuthorship W1931300061A5069362975 @default.
- W1931300061 hasAuthorship W1931300061A5089132706 @default.
- W1931300061 hasConcept C121608353 @default.
- W1931300061 hasConcept C126322002 @default.
- W1931300061 hasConcept C134306372 @default.
- W1931300061 hasConcept C147483822 @default.
- W1931300061 hasConcept C153911025 @default.
- W1931300061 hasConcept C159654299 @default.
- W1931300061 hasConcept C185592680 @default.
- W1931300061 hasConcept C197336794 @default.
- W1931300061 hasConcept C203014093 @default.
- W1931300061 hasConcept C33923547 @default.
- W1931300061 hasConcept C502942594 @default.
- W1931300061 hasConcept C553184892 @default.
- W1931300061 hasConcept C71924100 @default.
- W1931300061 hasConcept C86803240 @default.
- W1931300061 hasConcept C96232424 @default.
- W1931300061 hasConceptScore W1931300061C121608353 @default.
- W1931300061 hasConceptScore W1931300061C126322002 @default.
- W1931300061 hasConceptScore W1931300061C134306372 @default.
- W1931300061 hasConceptScore W1931300061C147483822 @default.
- W1931300061 hasConceptScore W1931300061C153911025 @default.
- W1931300061 hasConceptScore W1931300061C159654299 @default.
- W1931300061 hasConceptScore W1931300061C185592680 @default.
- W1931300061 hasConceptScore W1931300061C197336794 @default.
- W1931300061 hasConceptScore W1931300061C203014093 @default.
- W1931300061 hasConceptScore W1931300061C33923547 @default.
- W1931300061 hasConceptScore W1931300061C502942594 @default.
- W1931300061 hasConceptScore W1931300061C553184892 @default.
- W1931300061 hasConceptScore W1931300061C71924100 @default.
- W1931300061 hasConceptScore W1931300061C86803240 @default.
- W1931300061 hasConceptScore W1931300061C96232424 @default.
- W1931300061 hasLocation W19313000611 @default.
- W1931300061 hasOpenAccess W1931300061 @default.
- W1931300061 hasPrimaryLocation W19313000611 @default.
- W1931300061 hasRelatedWork W1971113195 @default.
- W1931300061 hasRelatedWork W1978039785 @default.
- W1931300061 hasRelatedWork W2023373095 @default.
- W1931300061 hasRelatedWork W2092608399 @default.
- W1931300061 hasRelatedWork W2120710734 @default.
- W1931300061 hasRelatedWork W2121744533 @default.
- W1931300061 hasRelatedWork W2122411218 @default.
- W1931300061 hasRelatedWork W2126375207 @default.
- W1931300061 hasRelatedWork W2149386286 @default.
- W1931300061 hasRelatedWork W2156969927 @default.
- W1931300061 hasRelatedWork W2296051580 @default.
- W1931300061 hasRelatedWork W2407317341 @default.
- W1931300061 hasRelatedWork W2564195475 @default.
- W1931300061 hasRelatedWork W2588900114 @default.
- W1931300061 hasRelatedWork W2599468991 @default.
- W1931300061 hasRelatedWork W2728851907 @default.
- W1931300061 hasRelatedWork W2796409416 @default.
- W1931300061 hasRelatedWork W3044424538 @default.
- W1931300061 hasRelatedWork W3108282003 @default.
- W1931300061 hasRelatedWork W3200237882 @default.
- W1931300061 isParatext "false" @default.
- W1931300061 isRetracted "false" @default.
- W1931300061 magId "1931300061" @default.
- W1931300061 workType "article" @default.